 CommentaryLooking ahead at the potential benefits of biotechnology-derived allergen therapeuticsJason Behrmann  Programmes de bioéthique, Université de Montréal, C.P. 6128, succursale centre-ville, Montréal, Québec, H3C 3J7, Canada  author email corresponding author email
Clinical and Molecular Allergy 2007,
5:3doi:10.1186/1476-7961-5-3 Abstract
While biotechnology-derived allergen therapeutics show promise in improving the safety of immunotherapy, they may prove to have additional benefits in comparison to conventional allergenic extracts that deserve commentary. These issues range from product stability and compatibility to medical practice issues, which will be the focus of this article. | 
on Google Scholar
